IMA - Ikena Oncology, Inc.
5.84
-0.200 -3.425%
Share volume: 5,223
Last Updated: 03-06-2026
Pharmaceutical Products/Biological Products, Except Diagnostic Substances:
0.17%
PREVIOUS CLOSE
CHG
CHG%
$6.04
-0.20
-0.03%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | 12-31-2024 | 03-31-2025 | 06-30-2025 | 09-30-2025 | |
|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | |
| Report Date | 05-13-2024 | 08-08-2024 | 11-07-2024 | 03-06-2025 | 05-08-2025 | 07-24-2025 | 11-12-2025 | |
| Cash flow financing | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 135.468 M | |
| Other financing cash flows | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 49.338 M | |
| Cash flow | -67.042 M | 0.000 | 0.000 | 0.000 | -2.630 M | 0.000 | 71.495 M | |
| Net income | -16.146 M | -13.730 M | -10.234 M | -9.124 M | -8.619 M | -2.767 M | -24.779 M | |
| Depreciation | 219.000 K | 92.000 K | 90.000 K | 89.000 K | 87.000 K | 87.000 K | -168.000 K | |
| Changes in inventories | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Changes in receivables | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Investing Cashflow | -48.738 M | 3.918 M | 9.454 M | 463.000 K | 7.932 M | 24.949 M | -37.331 M | |
| Net Borrowings | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Investing Activity Other | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Dividends Paid | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Exchange Rate Effect | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Capital Expenditures | -60.000 K | -185.000 K | -190.000 K | 0.000 | 0.000 | 0.000 | 0.000 | |
| Cash Change | -67.042 M | -8.584 M | 516.000 K | -5.797 M | -2.630 M | 21.527 M | 72.147 M |